Please forward this error best large cap stocks to invest in 2017 to sharedip-4325515496. Helping the world invest better since 1993. Will Social Security be there for me?
Should I Reverse Mortgage My Home? Should I Get a Long Term Care Policy? How Much House Can I Afford? What Tax Info Should I Keep? Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Should I reverse Mortgage My Home? The 10 Best Stocks of 2017 Find out how one industry dominated the winners of last year. Yet those gains paled in comparison to the massive returns that the 10 best stocks in 2017 managed to post. Includes only Russell 3000 index components. The return of biotech Nine of the top 10 stocks in 2017 were in the biotechnology industry. That makes sense, since the biotech niche was one of the best performers of the year in general. Madrigal benefited from positive mid-stage trial results for its treatment for non-alcoholic steatohepatitis.
Sangamo announced a key collaboration agreement with a major pharma player. Esperion rose on good trial results for its cholesterol reducing drug candidate. Ignyta got a buyout offer from a global giant in the industry. Nektar saw good news in treatments in the painkiller and immuno-oncology space.
Dynavax got FDA approval for its hepatitis B vaccine. Immunomedics saw good results from its breast cancer treatment sacituzumab govitecan in phase 2 trials. Spectrum climbed after good interim results in a mid-stage trial of lung cancer treatment poziotinib. Countless other biotechs enjoyed similar good news with their treatments, but larger companies saw smaller percentage gains due mostly to their greater size. Yet you need to take 2017’s gains in these stocks with a grain of salt, because the explosive returns that they posted last year came only after most of them suffered significant losses the previous year.
The real lessons to learn from these winners The more important thing about these winning stocks is what they all have in common. First and foremost, you can see that nearly all of them started out the year as true small-cap stocks, with only Nektar having a mid-cap market capitalization before its extensive gains for the year. Investors should also recognize that the merger and acquisition environment can make a huge difference to returns among top stocks. Finally, it’s often valuable to look at losing stocks to see whether their losses are justified.
Often, out-of-favor industries turn into favorites in future years, and biotech in 2016 and 2017 is just one example of that phenomenon playing out in various sectors of the market. Find 2018’s winners These 10 companies probably won’t be on this list in 2018, because other smaller companies will have taken their place. But by being aware of the broader trends in exciting growth industries, you can scope out the areas that are most likely to see similar gains in the future and then work to narrow down the possibilities in those industries to gather the cream of the crop for your portfolio. Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Dan Caplinger has been a contract writer for the Motley Fool since 2006.
As the Fool’s Director of Investment Planning, Dan oversees much of the personal-finance and investment-planning content published daily on Fool. With a background as an estate-planning attorney and independent financial consultant, Dan’s articles are based on more than 20 years of experience from all angles of the financial world. Could Nektar Therapeutics Be Worth More? Can Drugmakers Cure the Opioid Crisis?
This page may be out of date. Save your draft before refreshing this page. Submit any pending changes before refreshing this page. Please include your IP address in your email. Throughout much of modern history, investing in stocks has been one of the most effective and efficient ways for individuals and families to accumulate capital, build wealth, and grow their passive income. But the truth is that a well-chosen collection of stocks, particularly as part of a portfolio of diversified assets and asset classes, can provide freedom from financial worry as well as flexibility to pursue your passions on your own time. Here’s what you need to know about investing in stocks.